EMP2 antibodies and their therapeutic uses

US8318906B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• Jonathan Braun · Calabasas, US
• Lynn K. Gordon · Calabasas, US
• Kaori Shimizaki · Los Angeles, US
• Madhuri Wadegra-Dhawan · Fontana, US
• Kathy A. Kelly · Santa Monica, US
• Anna M. Wu · West Hollywood, US

Key dates

• Filing date: Oct 8, 2008
• Grant date: Nov 27, 2012
• Expiry date: Oct 8, 2028

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2319/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides methods and compositions useful in the treatment or prevention of Chlamydia infections and cancer. The methods and compositions inhibit the entry of Chlamydia into a host cell expressing EMP2 by interfering with the interaction between the Chlamydia and EMP2. The methods and compositions target cancers which express or overexpress EMP2 nucleic acids and polypeptides by targeting EMP2.